Mechanistic investigations have suggested that PP2A inhibition plays a role in CML stem cell renewal by modulating Abelson helper integration site-1 (AHI-1)30. The gene discussed is AHI1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.